Capital Wealth Alliance, LLC Logic Bio Therapeutics, Inc. Transaction History

Capital Wealth Alliance, LLC

  • $166 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 28, 2020
SELL
$4.06 - $11.0 $2,029 - $5,500
-500 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.01 - $11.01 $3,505 - $5,505
500 New
500 $5,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Capital Wealth Alliance, LLC Portfolio

Follow Capital Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Alliance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email